Abstracts tagged "race/ethnicity"

Abstract Number: 1258 • ACR Convergence 2020
Trajectory of Damage Accrual in African-American vs. Caucasian Systemic Lupus Erythematosus
Romy Kallas¹, Jessica Li², Daniel Goldman³ and Michelle Petri³, ¹Johns Hopkins Medical Institution, Baltimore, MD, ²Johns Hopkins University, Baltimore, MD, ³Johns Hopkins University School of Medicine, Timonium, MD
Background/Purpose: African-Americans have a higher incidence/prevalence of SLE, more lupus nephritis, higher rates of end stage renal disease and higher mortality than Caucasians. The aim…
Abstract Number: 0245 • ACR Convergence 2020
Systemic Lupus Erythematosus Phenotype Risk Score Identifies Undiagnosed Cases in a Large Electronic Health Record
April Barnado¹, Robert Carroll¹ and Lee Wheless¹, ¹Vanderbilt University Medical Center, Nashville, TN
Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous disease with patients often presenting with non-specific symptoms that can cause delays in diagnosis. Phenotype risk scores…
Abstract Number: 1291 • ACR Convergence 2020
Depressed Symptomatology Persists over Time in the Majority of Systemic Lupus Erythematosus Patients and Is Independent of Disease Activity
Sara Kellahan¹, Xinliang Huang¹, Daphne Lew², Hong Xian³, Seth Eisen¹ and Alfred Kim⁴, ¹Division of Rheumatology, Washington University in St. Louis School of Medicine, St. Louis, ²Division of Biostatistics, Washington University in St. Louis School of Medicine, St. Louis, ³Department of Epidemiology and Biostatistics, College for Public Health and Social Justice, Saint Louis University, St. Louis, ⁴Washington University School of Medicine, St. Louis, MO
Background/Purpose: Depression is a prevalent (24-30%) and significant comorbidity in patients with systemic lupus erythematosus (SLE) (1). As the American College of Rheumatology (ACR) classifies…
Abstract Number: 0250 • ACR Convergence 2020
Lupus Nephritis and Renal Outcomes in African-Americans: The Accelerating Medicines Partnership Cohort Experience
Andrea Fava¹, Jessica Li¹, Philip Carlucci², David Wofsy³, Judith James⁴, Chaim Putterman⁵, Betty Diamond⁶, Derek Fine⁷, Jose Monroy-Trujillo⁷, Kristin Haag⁷, Kristina Deonaraine⁸, The Accelerating Medicines Partnership in SLE Network⁹, William Apruzzese¹⁰, Jill Buyon¹¹ and Michelle Petri¹², ¹Johns Hopkins University, Baltimore, MD, ²New York University School of Medicine, New York, NY, ³University of California San Francisco, San Francisco, CA, ⁴Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation;Department of Pathology, University of Oklahoma Health Sciences Center;Department of Medicine, University of Oklahoma Health Sciences Center, Edmond, OK, ⁵Albert Einstein College of Medicine, Bronx, NY, ⁶Northwell Health, Manhasset, NY, ⁷Johns Hopkins University, Baltimore, ⁸New York University School of Medicine, New York, ⁹Multiple Institutions, Multiple Cities, ¹⁰., Boston, ¹¹Department of Medicine, NYU School of Medicine, New York, NY, ¹²Johns Hopkins University School of Medicine, Timonium, MD
Background/Purpose: The Accelerating Medicines Partnership (AMP) will use multi-omics modalities including single cell RNA sequencing to understand lupus nephritis with the ultimate goal to devise…
Abstract Number: 1398 • ACR Convergence 2020
The Isolated Nucleolar Pattern ANA Antibody in a Systemic Sclerosis Patient Cohort
Sabrina Elliott¹, Duncan Moore² and Virginia Steen², ¹MedStar Georgetown Hospital, Alexandria, VA, ²Division of Rheumatology, Department of Medicine, MedStar Georgetown University Hospital, Washington, DC
Background/Purpose: Systemic Sclerosis (SSc) patients with an isolated nucleolar patterned ANA (NUC ANA) make up about 15% of the SSc population, although the specific nucleolar…
Abstract Number: 697 • 2019 ACR/ARP Annual Meeting
Differing Opinions on Clinical Research Between Healthcare Providers and Lupus Patients
Cristina Arriens¹, Dylan Forciea ², Judith James ¹ and Joan T. Merrill ³, ¹Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ²Oseberg, Oklahoma City, OK, ³Okalahoma Medical Research Foundation, Oklahoma City, OK
Background/Purpose: Although SLE disproportionately affects minority racial groups, this population is significantly under-represented in clinical trials, increasing risk for underpowered, incorrect conclusions in race-based sub-group…
Abstract Number: 1742 • 2019 ACR/ARP Annual Meeting
Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multi-Ethnic Cohort
Talia Diaz¹, Daniela Dominguez ¹, Edgar Jaeggi ², Andrea Knight ³, Carl A. Laskin ⁴, Lawrence Ng ¹, Franklin Silverio ¹, Earl D. Silverman ⁵ and Linda Hiraki ⁶, ¹Division of Rheumatology, The Hospital for Sick Children, Toronto, Canada, ²Fetal Cardiac Program, The Hospital for Sick Children, Toronto, Canada, ³Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, ⁴Mount Sinai Hospital, University of Toronto, Toronto, Canada, ⁵Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, ⁶Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Canada
Background/Purpose: Neonatal Lupus Erythematosus (NLE) is an acquired autoimmune disorder of newborns secondary to the transplacental passage of maternal anti-Ro/La antibodies. Prior studies have suggested…
Abstract Number: 1853 • 2019 ACR/ARP Annual Meeting
Racial Differences in Highly Effective Contraceptive Use Among Medicaid Beneficiaries with SLE
Jessica Williams¹, Chang Xu ¹, Karen Costenbader ¹, Bonnie Bermas ², Lydia Pace ³ and Candace Feldman ³, ¹Brigham and Women's Hospital, Boston, MA, ²UT Southwestern, Dallas, ³Brigham and Women's Hospital, Boston
Background/Purpose: Highly effective contraception (HEC), which includes intrauterine devices, implants and sterilization, is safe for women with SLE and has a < 1% failure rate…
Abstract Number: 881 • 2018 ACR/ARHP Annual Meeting
Association of Comorbidities with DAS28 Disease Status and Remission in Race/Ethnic Groups with Rheumatoid Arthritis
Sharon Dowell¹, Rodolfo Perez-Alamino², Christopher J. Swearingen³, Gail S. Kerr⁴ and Yusuf Yazici⁵, ¹Internal Medicine, Howard University, Washington, DC, ²Rheumatology Department, Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina, ³Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, ⁴Rheumatology, Washington DC VAMC and Georgetown and Howard University, Washington, DC, ⁵New York University School of Medicine, New York, NY
Background/Purpose: Racial/ethnic disparities in comorbidity (CM) in rheumatoid arthritis (RA) may confound treatment and outcomes. Rheumatic Disease Comorbidity Index (RDCI) is a validated tool predicting…
Abstract Number: 2803 • 2018 ACR/ARHP Annual Meeting
48-Year Trends in Systemic Sclerosis Mortality in the United States, 1968-2015: Steady Decrease for 15 Years after 33 Years of Continuous Increase
Eric Yen, Devanshu Singh and Ram R. Singh, UCLA, Los Angeles, CA
Background/Purpose: A comprehensive evaluation of long-term trends in systemic sclerosis (SSc) mortality is important to understand the influence of recent advances in SSc management and…
Abstract Number: 273 • 2018 ACR/ARHP Annual Meeting
Incidence of Systemic Lupus Erythematosus By Income: A Nationwide Study
Ali Duarte-Garcia¹, Cynthia S. Crowson², Rozalina McCoy¹, Stephanie Schilz³, Holly Van Houten⁴, Lindsey Sangaralingham⁴, Vaidehi R. Chowdhary⁵, Shreyasee Amin⁶, Kenneth J. Warrington⁷, Eric L. Matteson⁸ and Nilay Shah⁹, ¹Mayo Clinic College of Medicine and Science, Rochester, MN, ²Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Health Sciences Research, Mayo Clinic, Rochester, MN, ⁴Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, ⁵Internal Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁶Rheumatology, Mayo Clinic, Rochester, MN, ⁷Rheumatology, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, ⁸Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁹Health Care Policy and Research, Mayo Clinic College of Medicine and Science, Rochester, MN
Background/Purpose: The incidence of systemic lupus erythematosus (SLE) varies significantly across patients from different racial/ethnic backgrounds, and is highest in non-Caucasian populations. In addition, poverty…
Abstract Number: 219 • 2017 ACR/ARHP Annual Meeting
Disparities in Patients’ Expectations of Foot and Ankle Surgery
Mackenzie T. Jones¹, Elizabeth A. Cody¹, Shirin A. Dey², Jackie Szymonifka², Michael L. Parks³, Lisa A. Mandl⁴, Susan M. Goodman⁵ and Scott J. Ellis⁶, ¹Hospital for Special Surgery, New York, NY, ²Rheumatology, Hospital for Special Surgery, New York, NY, ³Orthopaedic Surgery, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁴Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, ⁵Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁶Hospital for Special Surgery/Weill Cornell Medicine, New York, NY
Background/Purpose: A previous study examining patients’ expectations of elective foot and ankle surgery found that race is significantly associated with expectations. In this study, using…
Abstract Number: 117 • 2016 ACR/ARHP Annual Meeting
The Relationship Between Socioeconomic Factors and Dmards Use in Rheumatoid Arthritis
Adegbenga Bankole, Rheumatology, Carilion Clinic, Roanoke, VA
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder affecting millions of Americans with societal costs estimated in the billions. With the expansion in…
Abstract Number: 1252 • 2016 ACR/ARHP Annual Meeting
Socioeconomic Status and Not Race Associated with Delay in Diagnosis and Treatment of Rheumatoid Arthritis
Rodolfo Perez-Alamino¹, Sharon Dowell², Gail S. Kerr³, Christopher Swearingen⁴, Yusuf Yazici⁵, Luis Espinoza⁶, Ignacio Garcia- Valladares⁷, Yvonne Sherrer⁸, Edward L. Treadwell⁹, Angelia Mosley-Williams¹⁰, Theresa Lawrence Ford¹¹, Akgun Ince¹², Mercedes Quinones², Jorge Flautero Arcos¹³ and Arielle Mcdonald¹⁴, ¹Rheumatology, Hospital Avellaneda, Tucuman, Argentina, Tucuman, Argentina, ²Howard University Hospital, Washington, DC, ³Washington DC VAMC, Georgetown University Hospital, Howard University Hospital, Washington, DC, ⁴Pediatrics & Biostatistics, University of Arkansas, Little Rock, AR, ⁵Rheumatology, New York University Medical Center, La Jolla, CA, ⁶Medicine-Section of Rheumatology, LSU Medical Center, New Orleans, LA, ⁷CIB, Guadalajara, Mexico, ⁸Rheum/Immunology, Arthritis Center, Fort Lauderdale, FL, ⁹Dept Medicine Div of Rheum, E Carolina Univ Sch of Med, Greenville, NC, ¹⁰John Dingell VAMC, Detroit, MI, ¹¹North Georgia Rheumatology Group, PC, Lawrenceville, GA, ¹²Arthitis Consultants Inc, Saint Louis University, St. Louis, MO, ¹³Rheumatology, Howard University Hospital, Washington, DC, ¹⁴Howard University, Washington, DC, DC
Socioeconomic Status and Not Race Associated with Delay in Diagnosis and Treatment of Rheumatoid Arthritis Background/Purpose: Ethnic disparities in outcomes of RA patients have been…
Abstract Number: 1469 • 2016 ACR/ARHP Annual Meeting
Coronary Territories Are Not Affected in Mexican Mestizo Patients with Rheumatoid Arthritis in Comparison to Matched Controls: Evaluation Using Speckle Tracking Echocardiography
Dionicio A. Galarza-Delgado¹, Iris J. Colunga-Pedraza^2,3,4, Jose Ramon Azpiri-Lopez⁵, Adrian Martinez-Moreno⁶, Rosa I. Arvizu-Rivera², Raymundo Vera-Pineda⁷, Alberto Cardenas-de La Garza³, Mario Alberto Garza-Elizondo⁸, Mario Alberto Benavides-González⁶, Miguel A. Ramos-Guzman⁶, Luis E. Gonzalez-Carrillo⁶ and Filiberto Hervert-Cavazos⁶, ¹Internal Medicine/Rheumatology, Hospital Universitario UANL, Monterrey, Mexico, ²Rheumatology, Hospital Universitario UANL, Monterrey, Mexico, ³Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, ⁴Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, ⁵Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, ⁶Cardiology, Hospital Universitario UANL, Monterrey, Mexico, ⁷Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, ⁸Rheumatology, Hospital Universitario UANL., Monterrey, N.L., Mexico
Background/Purpose: Atherosclerotic cardiovascular disease is the leading cause of death in patients with rheumatoid arthritis (RA). Two dimensional speckle tracking echocardiography (TSE) assess local and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.